This weeks news and information on manufacturing in Central Massachusetts

Having trouble viewing this email? View as a web page.

Marlborough drugmaker to focus on lucrative cancer treatment

Marlborough drugmaker RXi Pharmaceuticals is shifting its business strategy to focus on the development of the most potentially lucrative of its three treatment areas -- the immuno-oncology program, the company announced Tuesday.

Q&A Insights

Worcester marijuana grower preparing to open

Kris Krane, president and co-founder of 4Front Ventures opening a medical marijuana cultivation facility in Worcester, said he's not worried about the feds cracking down on his business.

Go here for more information

Beer bottle manufacturer to close Milford facility

Glass container manufacturer Ardagh Group announced Monday it will close its Milford production facility, which employs 250 people.

Boston Scientific receives FDA approval for non-opioid painkiller

Boston Scientific announced Thursday it has received regulatory approval for a new treatment for chronic pain without the use of opioids.

Primetals names new president and CEO of U.S. operation

Metal manufacturer Primetals Technologies on Wednesday named Yoshiharu Ikeda as its new president and CEO for the company's U.S. headquarters based in Worcester.

WPI, QCC get $4M for new photonics lab

Worcester Polytechnic Institute and Quinsigamond Community College announced Thursday they'll start a new photonics lab thanks to a $4-million Massachusetts Manufacturing Innovation Initiative grant.

Go here for more information

You are receiving this email because you are subscribed to Central Mass Manufacturing at WBJournal.com.

Click here to unsubscribe

Know a friend or colleague who would like to subscribe?

New subscribers can sign up here

Worcester Business Journal
172 Shrewsbury Street
Worcester MA, 01604